Singapore markets closed

Novo Nordisk A/S (0TDD.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
135.30+0.46 (+0.34%)
As of 08:00AM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 392.59%
S&P500 52-week change 323.23%
52-week high 3142.93
52-week low 368.37
50-day moving average 3116.39
200-day moving average 397.55

Share statistics

Avg vol (3-month) 322.41k
Avg vol (10-day) 327.33k
Shares outstanding 52.41B
Implied shares outstanding 6N/A
Float 83.19B
% held by insiders 10.00%
% held by institutions 19.74%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 39.40
Trailing annual dividend yield 36.97%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 320 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 36.55%
Operating margin (ttm)48.73%

Management effectiveness

Return on assets (ttm)25.24%
Return on equity (ttm)99.87%

Income statement

Revenue (ttm)244.24B
Revenue per share (ttm)54.60
Quarterly revenue growth (yoy)22.50%
Gross profit (ttm)N/A
EBITDA 117.85B
Net income avi to common (ttm)89.28B
Diluted EPS (ttm)3.03
Quarterly earnings growth (yoy)28.20%

Balance sheet

Total cash (mrq)9.3B
Total cash per share (mrq)2.09
Total debt (mrq)26.93B
Total debt/equity (mrq)27.22%
Current ratio (mrq)0.70
Book value per share (mrq)22.18

Cash flow statement

Operating cash flow (ttm)93.41B
Levered free cash flow (ttm)40.24B